These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16513855)

  • 1. The schizophrenia prodrome.
    White T; Anjum A; Schulz SC
    Am J Psychiatry; 2006 Mar; 163(3):376-80. PubMed ID: 16513855
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of schizophrenia.
    Marder SR
    J Clin Psychiatry; 1996; 57 Suppl 3():9-13; discussion 47. PubMed ID: 8626371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is memory impairment a rate limiter in cognitive behavioural therapy for chronic schizophrenia?
    Penadés R; Catalán R; Pujol N; Puig O; Guarch J; Masana G; Navarro V; Gastó C
    Psychother Psychosom; 2010; 79(2):129-30. PubMed ID: 20090401
    [No Abstract]   [Full Text] [Related]  

  • 4. A discriminant validity study of negative symptoms with a special focus on depression and antipsychotic medication.
    Lewine RR
    Am J Psychiatry; 1990 Nov; 147(11):1463-6. PubMed ID: 1977328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of treatment refractory schizophrenia.
    Morrison DP
    Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
    [No Abstract]   [Full Text] [Related]  

  • 6. Predicting medication-free treatment response in acute psychosis: cross-validation from the Finnish Need-Adapted Project.
    Bola JR; Lehtinen K; Aaltonen J; Räkköläinen V; Syvälahti E; Lehtinen V
    J Nerv Ment Dis; 2006 Oct; 194(10):732-9. PubMed ID: 17041284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive behaviour therapy in patients with schizophrenia who are not prescribed antipsychotic medication: a case series.
    Christodoulides T; Dudley R; Brown S; Turkington D; Beck AT
    Psychol Psychother; 2008 Jun; 81(Pt 2):199-207. PubMed ID: 18230197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive high-frequency repetitive transcranial magnetic stimulation in schizophrenia: a case study.
    Sverak T; Prikryl R; Mayerova M; Anderkova L
    J ECT; 2014 Dec; 30(4):e51-3. PubMed ID: 25181021
    [No Abstract]   [Full Text] [Related]  

  • 9. Definitions of response and remission in schizophrenia: recommendations for their use and their presentation.
    Leucht S; Davis JM; Engel RR; Kissling W; Kane JM
    Acta Psychiatr Scand Suppl; 2009; (438):7-14. PubMed ID: 19132961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Better prognosis due to new treatment approaches. Therapy of schizophrenia in 2002].
    Janssen B; Gaebel W
    MMW Fortschr Med; 2002 May; Suppl 2():72-6, 78. PubMed ID: 12070858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive behavior therapy for schizophrenia: a meta-analytical review of randomized controlled trials.
    Sarin F; Wallin L; Widerlöv B
    Nord J Psychiatry; 2011 Jun; 65(3):162-74. PubMed ID: 21563994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mental illness spectrum.
    Lobo DM; Agius M
    Psychiatr Danub; 2012 Sep; 24 Suppl 1():S157-60. PubMed ID: 22945212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive behavioural therapy for auditory hallucinations: effectiveness and predictors of outcome in a specialist clinic.
    Thomas N; Rossell S; Farhall J; Shawyer F; Castle D
    Behav Cogn Psychother; 2011 Mar; 39(2):129-38. PubMed ID: 21062528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on treatment needs in schizophrenia.
    Meise U; Fleischhacker WW
    Br J Psychiatry Suppl; 1996 May; (29):9-16. PubMed ID: 8733818
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dissociative identity disorder or schizophrenia?].
    Tschöke S; Steinert T
    Fortschr Neurol Psychiatr; 2010 Jan; 78(1):33-7. PubMed ID: 19847739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple schizophrenia in an adolescent.
    Valentí M; Castro-Fornieles J; Lázaro ML; Sugrañes G; Baeza I
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):589-90. PubMed ID: 19877985
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacologic treatment of the psychotic symptoms in schizophrenia].
    Goldchluk A
    Vertex; 2002; 13 Suppl 1():4-11. PubMed ID: 12122421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New aspects in the diagnosis, pathogenesis and therapy of schizophrenic negative symptoms].
    Müller-Spahn F; Modell S; Thomma M
    Nervenarzt; 1992 Jul; 63(7):383-400. PubMed ID: 1354331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The first psychotic episode].
    Vacheron MN
    Encephale; 2013 Sep; 39 Suppl 2():S124-5. PubMed ID: 24084423
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of acute and chronic psychoses in childhood and adolescence].
    Eggers Ch
    MMW Fortschr Med; 2005 Dec; 147(48):41, 43-5. PubMed ID: 16389861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.